Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anna Richo Insider Profile
4 Followers
Anna Richo, SVP & CCO at Amgen, holds 6.31K shares in Exelon (Ticker: EXC), holds 2.62K shares in Illumina (Ticker: ILMN), holds 0.00 shares in Adamas Pharmaceuticals (Ticker: ADMS).
Profitable Transactions
1 out of 9 Profitable Transactions
Average Return
-28.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Anna Richo holds in companies
Most Profitable Insider Trade
The most profitable trade made by Anna Richo
Anna Richo's Trading History
Amgen
Aug 01, 2012
SVP & CCO
Uninformative Buy
―
$13.21M
Adamas Pharmaceuticals
Nov 24, 2021
―
Uninformative Sell
―
$0.00
Exelon
Jan 03, 2025
Director
Uninformative Buy
41.26K
$239.20K
Illumina
May 22, 2024
Director
Uninformative Buy
―
$357.85K
List of latest transactions for each holding click on a transaction to see Anna Richo's performance on stock
You May Also Like
Anna Richo insider profile FAQ
What is the percentage of profitable transactions made by Anna Richo?
The percentage of profitable transactions made by Anna Richo is 11%.
What is the average return per transaction made by Anna Richo?
The average return per transaction made by Anna Richo is -28.00%.
What stocks does Anna Richo hold?
Anna Richo holds: AMGN, ADMS, EXC, ILMN stocks.
What was Anna Richo’s latest transaction?
Anna Richo latest transaction was an Uninformative Buy of $41.26K.
What was Anna Richo's most profitable transaction?
Anna Richo’s most profitable transaction was an Informative Sell of AMGN stock on February 24, 2010. The return on the trade was 10.20%.
What is Anna Richo's role in Amgen?
Anna Richo's role in Amgen is SVP & CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.